5,6-Dihydroxytryptamine
Serotonergic neurotoxin
From Wikipedia, the free encyclopedia
5,6-Dihydroxytryptamine (5,6-DHT) is a monoaminergic neurotoxin and tryptamine derivative related to serotonin (5-hydroxytryptamine) and 5,7-dihydroxytryptamine (5,7-DHT).[1][2][3] It is a relatively selective serotonergic neurotoxin, but also acts as a dopaminergic and noradrenergic neurotoxin at higher doses.[1][2][3] In addition, it produces widespread generalized toxicity at higher doses.[1] Its selective serotonergic neurotoxicity is due to its high affinity for the serotonin transporter (SERT).[2] Because of its SERT affinity, 5,6-DHT has activity as a serotonin reuptake inhibitor.[1]
| Clinical data | |
|---|---|
| Other names | 5,6-DHT |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.023.464 |
| Chemical and physical data | |
| Formula | C10H12N2O2 |
| Molar mass | 192.218 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
The compound can be used in scientific research to lesion the brain serotonergic system in animals.[1][2][3] It has a number of limitations and disadvantages relative to 5,7-DHT however, which have made 5,7-DHT a more preferred serotonergic neurotoxin in scientific research.[3][1][2] Administration of 5,6-DHT (and 5,7-DHT) to animals causes dramatic behavioral changes.[1]
5,6-DHT was first described in the scientific literature by 1971.[1][2][3][4]